2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 14:32 (2548 d 01:44 ago) – Posting: # 11336
Views: 34,547


» Followed by:
» If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.
» … provided that the group meets minimum requirements for a complete bioequivalence study.

According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

 Admin contact
21,011 posts in 4,380 threads, 1,460 registered users;
online 20 (0 registered, 20 guests [including 11 identified bots]).
Forum time: Thursday 16:16 CEST (Europe/Vienna)

If you obey all the rules,
you will miss all the fun.    Katharine Hepburn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz